See Credit Details Below
Overview
Why You Should Attend
Patent law is an ever-changing battlefield. The Federal Circuit and the U.S. Patent and Trademark Office (PTO) are continually reshaping it every year. This program will teach you about some of the key developments in 2024, as well as important trends and strategies that can be made to work for you. An experienced faculty will cover developments in district court litigation, appellate practice, the USPTO and ethics considerations.
This year’s topics include the impact of AI on the biopharma industry, including on patents protecting biopharma products, IP strategy and life cycle management for biologic drug products, the impact of the Federal Circuit’s decision in In re Cellect on the double patenting doctrine and its effect on protection for life sciences inventions, practice before the PTAB on life sciences patents, proving infringement in ANDA cases, and ethics issues confronting patent lawyers and how to identify and mitigate associated risks in practice. Join us for these important and useful discussions on pressing issues in pharmaceutical and biotech patent law.
What You Will Learn
After completing this program, participants will be able to:
- Understand the impact of artificial intelligence
- Review issues in proving indirect infringement in ANDA cases
- Explore the consequences of In re Cellect on building patent protection
- Review PTAB practice for life sciences patents
- Review key considerations for managing the IP protecting biologic products from both an in-house and outside counsel perspective
- Explore ethics issues that impact patent practice
Who Should Attend
Attorneys who will find this program helpful include: in-house attorneys who want to understand the latest developments in biotech and pharmaceutical patent law including changes in the substantive law, future trends and strategic considerations; and, litigators who need to understand how to best make use of developing law relating to therapeutic antibodies, generic challenges to branded drug products, patent clearance best practices and strategies, and patent eligibility for life sciences patents.
Program Level: Intermediate
Prerequisites: An interest in the latest developments in pharmaceutical and biotech patent law.
Advanced Preparation: None